MAP2K7 and acute myeloid leukemia: Berthon et al. [41] confirmed that blocking MEK inhibited PD-L1 transcription in the AML cell lines THP-1 and U937, suggesting that MEK is an important regulator of PD-L1 expression in leukemic cells.